Zoetis Inc. (NYSE:ZTS) Shares Acquired by Mount Yale Investment Advisors LLC

Mount Yale Investment Advisors LLC boosted its holdings in Zoetis Inc. (NYSE:ZTS) by 12.7% in the second quarter, HoldingsChannel.com reports. The firm owned 4,366 shares of the company’s stock after acquiring an additional 493 shares during the period. Mount Yale Investment Advisors LLC’s holdings in Zoetis were worth $757,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other institutional investors have also recently added to or reduced their stakes in the company. Price T Rowe Associates Inc. MD boosted its holdings in shares of Zoetis by 31.0% in the 4th quarter. Price T Rowe Associates Inc. MD now owns 13,716,681 shares of the company’s stock valued at $2,707,262,000 after buying an additional 3,244,074 shares during the period. Sarasin & Partners LLP grew its holdings in shares of Zoetis by 546.3% during the second quarter. Sarasin & Partners LLP now owns 2,253,590 shares of the company’s stock valued at $390,682,000 after purchasing an additional 1,904,899 shares during the last quarter. Swedbank AB acquired a new stake in shares of Zoetis during the 1st quarter worth approximately $210,815,000. Public Employees Retirement Association of Colorado bought a new stake in shares of Zoetis in the 4th quarter worth approximately $242,757,000. Finally, CIBC Private Wealth Group LLC boosted its position in Zoetis by 122.6% during the 4th quarter. CIBC Private Wealth Group LLC now owns 1,448,665 shares of the company’s stock valued at $285,923,000 after purchasing an additional 797,884 shares during the period. Institutional investors own 92.80% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of equities research analysts have issued reports on ZTS shares. BTIG Research raised their target price on Zoetis from $220.00 to $225.00 and gave the company a “buy” rating in a research note on Monday, August 12th. Argus upgraded shares of Zoetis to a “strong-buy” rating in a research report on Friday, August 9th. Stifel Nicolaus upped their target price on shares of Zoetis from $200.00 to $210.00 and gave the stock a “buy” rating in a research report on Wednesday, September 18th. Finally, Piper Sandler lifted their price target on Zoetis from $195.00 to $210.00 and gave the company an “overweight” rating in a report on Wednesday, August 14th. Nine equities research analysts have rated the stock with a buy rating and one has given a strong buy rating to the company. According to MarketBeat, Zoetis presently has an average rating of “Buy” and an average price target of $220.38.

Zoetis Trading Up 0.5 %

Shares of NYSE:ZTS opened at $193.59 on Tuesday. The company has a 50 day moving average of $185.01 and a 200-day moving average of $174.42. The company has a current ratio of 3.45, a quick ratio of 2.09 and a debt-to-equity ratio of 1.32. The firm has a market cap of $88.33 billion, a P/E ratio of 37.30, a P/E/G ratio of 2.98 and a beta of 0.88. Zoetis Inc. has a twelve month low of $144.80 and a twelve month high of $201.92.

Zoetis (NYSE:ZTS) last released its earnings results on Tuesday, August 6th. The company reported $1.56 earnings per share for the quarter, topping analysts’ consensus estimates of $1.49 by $0.07. Zoetis had a return on equity of 50.67% and a net margin of 26.29%. The firm had revenue of $2.36 billion during the quarter, compared to the consensus estimate of $2.31 billion. During the same period in the prior year, the firm posted $1.41 earnings per share. The firm’s revenue for the quarter was up 8.3% compared to the same quarter last year. As a group, analysts anticipate that Zoetis Inc. will post 5.84 earnings per share for the current fiscal year.

Zoetis Company Profile

Zoetis Inc engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses.